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Abstract
Polycystic ovary syndrome (PCOS) is one of the most common reproductive disorder in premenopausal women and is frequently accom-
panied by the presence of cardiovascular risk factors. It has also been recognized that PCOS women are characterized by cardiopulmonary
impairment. Reduced cardiopulmonary functional capacity and the autonomic dysfunction associated with abnormal heart rate recovery
might be responsible for the increased cardiovascular risk in patients with PCOS. Exercise training has beneficial effects on cardiopulmo-
nary functional capacity and reduces the risk of cardiovascular disease in PCOS women.
(Pol J Endocrinol 2010; 61 (2): 207–209)
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Streszczenie
Zespół policystycznych jajników (PCOS, polycystic ovary syndrome) jest jednym z najczęstszych zaburzeń endokrynologicznych u kobiet w wieku
reprodukcyjnym. Zespół ten często współwystępuje z czynnikami ryzyka chorób sercowo-naczyniowych. Ponadto wiąże się on z upośle-
dzeniem czynności układu sercowo-naczyniowego i płuc. Zmniejszenie wydolności krążeniowo-oddechowej oraz dysfunkcja układu
autonomicznego, która wiąże się z zaburzeniem normalizacji częstości rytmu serca może być przyczyną zwiększonego ryzyka sercowo-
-naczyniowego u kobiet z zespołem policystycznych jajników. Ćwiczenia fizyczne mają korzystny wpływ na wydolność krążeniowo-
-oddechową i powodują zmniejszenie ryzyka sercowo-naczyniowego w tej grupie chorych. (Endokrynol Pol 2010; 61 (2): 207–209s)
Słowa kluczowe: zespół policystycznych jajników, wydolność krążeniowo-oddechowa, ćwiczenia fizyczne
Introduction
Polycystic ovary syndrome (PCOS) is one of the most
common reproductive disorders and affects between
5-10% of premenopausal women [1]. It is characterized
by chronic anovulation, clinical and/or biochemical hy-
perandrogenism, and polycystic ovary morphology.
PCOS is associated with several metabolic aberrations,
of which insulin resistance and hyperinsulinaemia are
the most significant. Insulin resistance is present in up
to 70% of women with PCOS and seems to have a key
role in the pathogenesis of hyperandrogenaemia and
anovulation [2]. Women with PCOS also exhibit obesi-
ty, especially with abdominal fat distribution, dyslipi-
daemia, elevated blood pressure, and an increased prev-
alence of glucose intolerance and type 2 diabetes [2–5].
About 46% of patients with PCOS fulfil the criteria for
metabolic syndrome [6]. Recently, low-grade chronic
inflammation has been a related complication observed
in PCOS. There is evidence indicating increased levels
of C-reactive protein, leukocyte numbers, and pro-in-
flammatory cytokines such as IL-6, IL-18, and TNF-a in
PCOS [7]. Altered vascular and endothelial function in
women with PCOS is well documented [8]. Insulin re-
sistance together with other metabolic abnormalities,
elevated markers of chronic inflammation, and endot-
helial dysfunction suggest that PCOS women are at in-
creased risk of cardiovascular disease although not all
studies are consistent with this.
Cardiopulmonary functional capacity
Cardiopulmonary functional capacity assessed using
a cardiopulmonary exercise test and defined mainly by
maximal oxygen consumption (VO2max) is considered
a determinant of cardiovascular disease. There is evi-
dence that increased VO2max is associated with de-
creased cardiovascular mortality [9]. Orio et al. were the
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first, in 2006, assessed cardiopulmonary capacity in
young overweight PCOS women [10]. They demon-
strated significantly reduced VO2max, oxygen consump-
tion at the anaerobic threshold (VO2AT), and maximal
workload at peak exercise in PCOS patients compared
with healthy women. VO2max correlated with homeo-
stasis model assessment (HOMA), glucose-to-insulin
ratio, and the area under the curve for insulin (AUCins)
in PCOS subjects. The authors concluded that women
with PCOS are characterized by cardiopulmonary im-
pairment with reduced cardiopulmonary functional
capacity that may increase the risk of cardiovascular
disease. They also hypothesized that insulin resistance
is the key pathophysiological mechanism for the re-
duced functional capacity, probably due to its influence
on mitochondrial function. Insulin is a regulator of
muscle proteins and can stimulate the synthesis of mi-
tochondrial proteins. An impaired capacity of mitochon-
dria in skeletal muscle was observed in patients with
type 2 diabetes. Moreover, there is evidence that hy-
perinsulinaemia is associated with low skeletal muscle
strength, which may subsequently worsen ventilatory
function [11].
Cosar et al. compared VO2max and the resting meta-
bolic rate in PCOS women with central adiposity and
in age- and body mass index (BMI)-matched controls
with a different body fat distribution [12]. The authors
did not observe differences in VO2max and resting met-
abolic rate between the two groups, so they concluded
that central obesity was not a determinant of decreased
exercise capacity in women with PCOS. This suggests
that factors other than central adiposity, perhaps insu-
lin resistance, are the cause of reduced functional ca-
pacity in PCOS patients.
Heart rate recovery
Giallauria et al., contrary to the previous study, showed
that overweight PCOS women demonstrated impair-
ment in VO2max and VO2AT [13]. Moreover, they ob-
served reduced heart rate recovery (HRR) in PCOS pa-
tients after maximal cardiopulmonary exercise stress
test. Abnormal HRR correlated inversely with BMI and
AUCins, and there was a relationship between VO2max
and the AUCglu/AUCins ratio in the PCOS patients. HRR
after exercise is a marker of autonomic function. Atten-
uation of this parameter reflects unbalanced autonom-
ic activity with reduced parasympathetic components.
Abnormal HRR is an independent cardiovascular risk
factor and is associated with increased cardiac mortali-
ty [14]. Previous studies indicated that reduced HRR is
associated with elevated fasting glucose levels and dia-
betes [15, 16]. In those studies the authors suggested
that in PCOS women, insulin resistance led not only to
reduced cardiopulmonary capacity, but also to auto-
nomic dysfunction, which might be responsible for the
increased cardiovascular risk.
Tekin et al. determined heart rate recovery, systolic
blood pressure (SBP) response to exercise, and heart rate
variability (HRV) in patients with PCOS [17]. They
showed lower HRR, higher SBP at peak exercise, de-
layed recovery of SBP after exercise, and depressed
HRV. All four parameters indicate sympathetic hyper-
activity, which is associated with cardiovascular disease.
An interesting hypothesis is that sympathetic hyperac-
tivity may play a role in the development of polycystic
ovaries. High levels of norepinephrine were observed
in rats with induced polycystic ovaries. In women with
PCOS, polycystic ovaries have more catecholaminergic
nerve fibres than normal ovaries. Furthermore, auto-
nomic dysfunction may influence inappropriate gona-
dotropin secretion and in this way influence the patho-
genesis of PCOS.
The role of exercise
Regular exercise has beneficial effects on reproductive
and metabolic functions in women with PCOS. Recent-
ly, favourable results of exercise training on cardiopul-
monary functional capacity in PCOS patients was also
documented. Randeva et al. examined young over-
weight and obese PCOS women who had taken a six-
month exercise program (at least three walks per week,
each walk of 20- to 60-minute duration) [18]. The au-
thors observed a significant rise in VO2max, a significant
fall in plasma total homocysteine level, and a decrease
in waist-to-hip ratio (WHR) after the 6-month program
compared with baseline in the training group. There
was no significant change in BMI. The increase in
VO2max and decrease in homocysteine levels were not
explained by changes in BMI or biochemical parame-
ters. Hyperhomocysteinaemia-inducing endothelial
dysfunction, leading to impairment of the coagulation
system and activation of oxidative stress, is considered
an independent cardiovascular risk factor. Higher ho-
mocysteine levels were found in PCOS women and
were associated with insulin resistance [19, 20]. Regu-
lar exercise, by lowering plasma homocysteine levels
and increasing VO2max, may reduce the risk of cardio-
vascular disease in women with PCOS.
Vigorito et al. assessed the effects of a three-month
structured exercise training program on cardiopulmo-
nary functional capacity in young overweight women
with PCOS [21]. The authors observed a significant im-
provement in peak oxygen consumption and in maxi-
mal workload in the PCOS patients after 3 months of
the program. The exercising women with PCOS showed
a significant reduction in BMI and CRP levels and im-
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provement in insulin sensitivity. This study provided
evidence that exercise improves metabolic functions,
decreases chronic inflammation, and improves cardiop-
ulmonary functional capacity in women with PCOS.
Orio et al. observed similar results of an exercise train-
ing program in PCOS women [22]. Patients with PCOS
had improvements in BMI, fasting insulin, AUCins, AUCglu/
/AUCins ratio, HDL cholesterol, LDL cholesterol, and
VO2max after 12 weeks of the exercise program compared
with baseline. After 12 weeks of exercises the subjects
were divided into two groups: the first underwent an-
other 12 weeks of training and the second a 12-week
detraining period. After 24 weeks the authors observed
further improvement in all the above parameters in the
training group compared with baseline and the 12-week
follow-up. In the detrained group, in contrast, the pa-
rameters worsened and were similar to baseline. The
authors concluded that the detraining period resulted
in a loss of the profitable metabolic and cardiopulmo-
nary effects obtained after the exercise program in the
PCOS women.
Conclusions
A cardiopulmonary exercise test allows a complex eval-
uation of the cardiopulmonary system and metabolic
transformation at the cell level. Maximal oxygen con-
sumption is an important predictor of cardiovascular
disease. Current data agree that PCOS women have
impaired cardiopulmonary functional capacity. Some
studies suggest alterations in autonomic neural control
of the cardiovascular system in patients with PCOS.
Moreover, PCOS is frequently accompanied by the pres-
ence of other cardiovascular risk factors, such as obesi-
ty, insulin resistance, hyperlipidaemia, elevated mark-
ers of low-grade chronic inflammation, endothelial dys-
function [8], increased carotid intima-media thickness
[23], and increased coronary calcium [24]. These find-
ings suggest increased cardiovascular mortality in wom-
en with PCOS.
An important role in the treatment of PCOS is life-
style modification, including diet and exercise. Even
a small reduction in body weight improves anthropo-
metric indices, reduces ovarian volume and microfol-
licle number, and can restore ovulatory cycles, allow-
ing spontaneous pregnancy [25]. Exercise has many
benefits for health and cardiovascular risk factors: it
decreases the levels of proinflammatory markers, in-
creases insulin sensitivity, and improves cardiopulmo-
nary functional capacity in PCOS women. Therefore,
it may reduce cardiovascular morbidity and mortality
in these women.
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